DCCR
C603
Phase 3 small_molecule active
Quick answer
DCCR for Prader-Willi Syndrome is a Phase 3 program (small_molecule) at SOLENO THERAPEUTICS INC with 4 ClinicalTrials.gov record(s).
Program details
- Company
- SOLENO THERAPEUTICS INC
- Indication
- Prader-Willi Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active